CGL
BSX icon

Clarius Group LLC’s Boston Scientific BSX Stock Holding History

Clarius Group LLC’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$762K Sell
7,987
-2
-0% -$196 0.04% 151
2025
Q3 		$780K Sell
7,989
-2,278
-22% -$236K 0.05% 151
2025
Q2 		$1.1M Sell
10,267
-1,226
-11% -$124K 0.06% 135
2025
Q1 		$1.16M Buy
11,493
+2,968
+35% +$299K 0.07% 129
2024
Q4 		$761K Buy
8,525
+567
+7% +$49.9K 0.05% 149
2024
Q3 		$664K Sell
7,958
-112
-1% -$8.83K 0.05% 173
2024
Q2 		$621K Sell
8,070
-271
-3% -$19.8K 0.04% 186
2024
Q1 		$571K Sell
8,341
-1,184
-12% -$76.1K 0.04% 201
2023
Q4 		$551K Sell
9,525
-423
-4% -$22.6K 0.05% 219
2023
Q3 		$525K Sell
9,948
-2,149
-18% -$113K 0.05% 208
2023
Q2 		$654K Buy
12,097
+60
+0.5% +$3.13K 0.05% 207
2023
Q1 		$602K Buy
12,037
+52
+0.4% +$2.45K 0.05% 215
2022
Q4 		$555K Buy
11,985
+655
+6% +$28.4K 0.05% 229
2022
Q3 		$439K Sell
11,330
-141
-1% -$5.66K 0.04% 244
2022
Q2 		$428K Buy
11,471
+1,229
+12% +$50K 0.04% 246
2022
Q1 		$435K Hold
10,242
– – 0.03% 269
2021
Q4 		$435K Buy
10,242
+169
+2% +$7.1K 0.03% 269
2021
Q3 		$437K Buy
10,073
+769
+8% +$34K 0.04% 244
2021
Q2 		$398K Buy
9,304
+335
+4% +$14.1K 0.04% 257
2021
Q1 		$347K Buy
8,969
+260
+3% +$9.84K 0.03% 262
2020
Q4 		$313K Sell
8,709
-692
-7% -$24.9K 0.03% 255
2020
Q3 		$359K Buy
9,401
+50
+0.5% +$1.93K 0.05% 189
2020
Q2 		$328K Buy
9,351
+356
+4% +$12.8K 0.05% 199
2020
Q1 		$294K Buy
8,995
+951
+12% +$37.2K 0.06% 182
2019
Q4 		$342K Sell
8,044
-1,136
-12% -$47.5K 0.05% 180
2019
Q3 		$374K Buy
9,180
+2,357
+35% +$99.9K 0.07% 156
2019
Q2 		$293K Sell
6,823
-1,046
-13% -$40.2K 0.06% 175
2019
Q1 		$302K Buy
+7,869
New +$301K 0.07% 140

Other funds holding BSX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Clarius Group LLC's BSX Position: Q4 2025 in Review

Clarius Group LLC reduced its Boston Scientific (BSX) stake by 0.03% in Q4 2025, selling an estimated $196 and leaving 7,987 shares worth $762K. The position accounts for 0.04% of the portfolio, ranked #151.

Clarius Group LLC first reported a position in BSX in Q1 2019 and has held it in 28 quarters since. The position peaked at $1.16M in Q1 2025. 1,784 funds tracked by Wall St. Rank hold BSX as of Q4 2025.

  • Clarius Group LLC held 7,987 shares of Boston Scientific worth $762K as of Q4 2025.
  • Clarius Group LLC sold 2 Boston Scientific shares in Q4 2025, an estimated $196.
  • Boston Scientific made up 0.04% of Clarius Group LLC's portfolio in Q4 2025, its #151 holding.
  • Clarius Group LLC first reported a position in Boston Scientific in Q1 2019 and has held it in 28 quarters since.
  • Clarius Group LLC's Boston Scientific position peaked at $1.16M in Q1 2025.
  • 1,784 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2025.

Based on Clarius Group LLC's 13F filing for Q4 2025, filed 14 Jan 2026.